The Diagnosis of Sarcoidosis

Clinics in Chest Medicine

Volumn 36, Issue 4, 2015, Pages 585-602

  Govender, Praveen ^a   Berman, Jeffrey S ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biopsy; Differential diagnosis; Heerfordt syndrome; Hilar adenopathy; Lofgren's syndrome; Organ involvement; Sarcoidosis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

BRONCHOSCOPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENZYME BLOOD LEVEL; HUMAN; IMAGE GUIDED BIOPSY; INTERFERON GAMMA RELEASE ASSAY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MEDICAL HISTORY; MORBIDITY; PHYSICAL EXAMINATION; POPULATION RISK; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SYMPTOM ASSESSMENT; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TUBERCULIN TEST; BIOPSY; DIFFERENTIAL DIAGNOSIS; LYMPH NODE; PATHOLOGY; PROCEDURES;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPH NODES; SARCOIDOSIS;

EID: 84947764989     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2015.08.003     Document Type: Review

References (69)

1. Baughman R.P., Culver D.A., Judson M.A. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 2011, 183:573-581.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999, 160:736-755.
3. Judson M.A., Baughman R.P., Teirstein A.S., et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999, 16:75-86.
4. Judson M.A., Costabel U., Drent M., et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis 2014, 31:19-27.
5. Judson M.A. Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep 2014, 6:89.
6. Judson M.A., Thompson B.W., Rabin D.L., et al. The diagnostic pathway to sarcoidosis. Chest 2003, 123:406-412.
7. Valeyre D., Prasse A., Nunes H., et al. Sarcoidosis. Lancet 2014, 383:1155-1167.
8. Judson M.A. The clinical features of sarcoidosis: a comprehensive review. Clin Rev Allergy Immunol 2014, 49(1):63-78.
9. Baughman R.P., Teirstein A.S., Judson M.A., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001, 164:1885-1889.
10. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N Engl J Med 2007, 357:2153-2165.
11. O'Regan A., Berman J.S. Sarcoidosis. Ann Intern Med 2012, 156. ITC5-1-15.
12. Cozier Y.C., Berman J.S., Palmer J.R., et al. Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest 2011, 139:144-150.
13. Valeyre D., Soler P., Clerici C., et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988, 43:516-524.
14. Rybicki B.A., Iannuzzi M.C., Frederick M.M., et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001, 164:2085-2091.
15. Muller-Quernheim J., Gaede K.I., Fireman E., et al. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 2006, 27:1190-1195.
16. Kreiss K., Day G.A., Schuler C.R. Beryllium: a modern industrial hazard. Annu Rev Public Health 2007, 28:259-277.
17. Bouvry D., Mouthon L., Brillet P.Y., et al. Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J 2013, 41:115-122.
18. Nardi A., Brillet P.Y., Letoumelin P., et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J 2011, 38:1368-1373.
19. Yancey J., Luxford W., Sharma O.P. Clubbing of the fingers in sarcoidosis. JAMA 1972, 222:582.
20. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med 1975, 59:365-372.
21. Studdy P.R., Bird R. Serum angiotensin converting enzyme in sarcoidosis-its value in present clinical practice. Ann Clin Biochem 1989, 26(Pt 1):13-18.
22. Baughman R.P., Ploysongsang Y., Roberts R.D., et al. Effects of sarcoid and steroids on angiotensin-converting enzyme. Am Rev Respir Dis 1983, 128:631-633.
23. Stouten K., van de Werken M., Tchetverikov I., et al. Extreme elevation of serum angiotensin-converting enzyme (ACE) activity: always consider familial ACE hyperactivity. Ann Clin Biochem 2014, 51:289-293.
24. Gupta D., Chetty M., Kumar N., et al. Anergy to tuberculin in sarcoidosis is not influenced by high prevalence of tuberculin sensitivity in the population. Sarcoidosis Vasc Diffuse Lung Dis 2003, 20:40-45.
25. Inui N., Suda T., Chida K. Use of the QuantiFERON-TB Gold test in Japanese patients with sarcoidosis. Respir Med 2008, 102:313-315.
26. Gupta D., Kumar S., Aggarwal A.N., et al. Interferon gamma release assay (QuantiFERON-TB Gold in Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc Diffuse Lung Dis 2011, 28:95-101.
27. Vyas S., Thangakunam B., Gupta R., et al. Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis. Lung India 2015, 32:91-92.
28. Scadding J.G. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J 1961, 2:1165-1172.
29. Winterbauer R.H., Belic N., Moores K.D. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973, 78:65-71.
30. Reich J.M. Tissue confirmation of presumptive stage I sarcoidosis. J Bronchology Interv Pulmonol 2013, 20:103-105.
31. Reich J.M., Brouns M.C., O'Connor E.A., et al. Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest 1998, 113:147-153.
32. Mana J., Teirstein A.S., Mendelson D.S., et al. Excessive thoracic computed tomographic scanning in sarcoidosis. Thorax 1995, 50:1264-1266.
33. Keijsers RG, Veltkamp M, Grutters JC. Chest imaging. Clin Chest Med 2015, in press.
34. Valeyre D, Bernaudin JF, Jeny F, et al. Pulmonary sarcoidosis. Clin Chest Med 2015, in press.
35. Fasano M.B., Sullivan K.E., Sarpong S.B., et al. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine 1996, 75:251-261.
36. Pakhale S.S., Unruh H., Tan L., et al. Has mediastinoscopy still a role in suspected stage I sarcoidosis?. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23:66-69.
37. Sulavik S.B., Spencer R.P., Palestro C.J., et al. Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the noninvasive diagnosis of sarcoidosis. Chest 1993, 103:403-409.
38. Israel H.L., Sones M. Selection of biopsy procedures for sarcoidosis diagnosis. Arch Intern Med 1964, 113:255-260.
39. Navani N., Lawrence D.R., Kolvekar S., et al. Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial. Am J Respir Crit Care Med 2012, 186:255-260.
40. Ravini M., Ferraro G., Barbieri B., et al. Changing strategies of lung biopsies in diffuse lung diseases: the impact of video-assisted thoracoscopy. Eur Respir J 1998, 11:99-103.
41. Gilman M.J. Transbronchial biopsy in sarcoidosis. Chest 1983, 83:159.
42. Shorr A.F., Torrington K.G., Hnatiuk O.W. Endobronchial biopsy for sarcoidosis: a prospective study. Chest 2001, 120:109-114.
43. Agarwal R., Aggarwal A.N., Gupta D. Efficacy and safety of conventional transbronchial needle aspiration in sarcoidosis: a systematic review and meta-analysis. Respir Care 2013, 58:683-693.
44. Agarwal R., Srinivasan A., Aggarwal A.N., et al. Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Med 2012, 106:883-892.
45. von Bartheld M.B., Dekkers O.M., Szlubowski A., et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA 2013, 309:2457-2464.
46. Plit M., Pearson R., Havryk A., et al. Diagnostic utility of endobronchial ultrasound-guided transbronchial needle aspiration compared with transbronchial and endobronchial biopsy for suspected sarcoidosis. Intern Med J 2012, 42:434-438.
47. Oki M., Saka H., Kitagawa C., et al. Prospective study of endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue for diagnosis of sarcoidosis. J Thorac Cardiovasc Surg 2012, 143:1324-1329.
48. Gupta D., Dadhwal D.S., Agarwal R., et al. Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis. Chest 2014, 146:547-556.
49. Kantrow S.P., Meyer K.C., Kidd P., et al. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997, 10:2716-2721.
50. Drent M., Mansour K., Linssen C. Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med 2007, 28:486-495.
51. Bonfioli A.A., Orefice F. Sarcoidosis. Semin Ophthalmol 2005, 20:177-182.
52. Nessan V.J., Jacoway J.R. Biopsy of minor salivary glands in the diagnosis of sarcoidosis. N Engl J Med 1979, 301:922-924.
53. Harvey J., Catoggio L., Gallagher P.J., et al. Salivary gland biopsy in sarcoidosis. Sarcoidosis 1989, 6:47-50.
54. Stjernberg N., Truedson H., Bjornstad-Petersen H. Scalene node biopsy in sarcoidosis. Acta Med Scand 1980, 207:111-113.
55. Truedson H., Stjernberg N., Thunell M. Scalene lymph node biopsy. A diagnostic method in sarcoidosis. Acta Chir Scand 1985, 151:121-123.
56. Karagiannidis A., Karavalaki M., Koulaouzidis A. Hepatic sarcoidosis. Ann Hepatol 2006, 5:251-256.
57. Andonopoulos A.P., Papadimitriou C., Melachrinou M., et al. Asymptomatic gastrocnemius muscle biopsy: an extremely sensitive and specific test in the pathologic confirmation of sarcoidosis presenting with hilar adenopathy. Clin Exp Rheumatol 2001, 19:569-572.
58. Teirstein A.S., Machac J., Almeida O., et al. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007, 132:1949-1953.
59. Siltzbach L.E. The Kveim test in sarcoidosis. A study of 750 patients. JAMA 1961, 178:476-482.
60. Ma Y., Gal A., Koss M.N. The pathology of pulmonary sarcoidosis: update. Semin Diagn Pathol 2007, 24:150-161.
61. Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med 2007, 28:36-52.
62. Rosen Y. Four decades of necrotizing sarcoid granulomatosis: what do we know now?. Arch Pathol Lab Med 2015, 139:252-262.
63. Rossi G., Cavazza A., Colby T.V. Pathology of sarcoidosis. Clin Rev Allergy Immunol 2015, 49(1):36-44.
64. Ricker W., Clark M. Sarcoidosis; a clinicopathologic review of 300 cases, including 22 autopsies. Am J Clin Pathol 1949, 19:725-749.
65. Myers J.L., Tazelaar H.D. Challenges in pulmonary fibrosis: 6-problematic granulomatous lung disease. Thorax 2008, 63:78-84.
66. Judson M.A. The diagnosis of sarcoidosis. Clin Chest Med 2008, 29:415-427. viii.
67. Judson M.A., Baughman R.P. How many organs need to be involved to diagnose sarcoidosis?: an unanswered question that, hopefully, will become irrelevant. Sarcoidosis Vasc Diffuse Lung Dis 2014, 31:6-7.
68. Kassirer J.P. Our stubborn quest for diagnostic certainty. A cause of excessive testing. N Engl J Med 1989, 320:1489-1491.
69. Mitchell D.N., Scadding J.G., Heard B.E., et al. Sarcoidosis: histopathological definition and clinical diagnosis. J Clin Pathol 1977, 30:395-408.